A heating and freezing process known as dual thermal ablation can kill pancreatic cancer cells, according to new research from Binghamton University, State University at New York.
The collaborative study, conducted by researchers from academia and industry and funded by grants from the National Cancer Institute, used pancreatic cancer cells to investigate the effect of heating and freezing on cell death. The research was conducted by Robert Van Buskirk and John Baust, professors of biological sciences and directors at Binghamton University’s Institute of Biomedical Technology, and Kenneth Baumann, a graduate student studying biology.
“How do we solve the problem of pancreatic cancer when it comes to trying to get rid of the tumor, when chemo and radiation just simply doesn’t work?” said Van Buskirk. “The whole idea is, can one come up with a different surgical intervention that’s less invasive and more effective?
“In order to figure that out, you can commercially obtain pancreatic cancer cells and grow them on specialized plasticware,” Van Buskirk said. “The basic question is, are both freezing and heat in combination more effective than freezing or heat alone? If you freeze pancreatic cancer cells like you do in cryoablation, a lot of them die, but some will survive and regrow. If you heat them, they’ll die, but again some will come back. But with dual-thermal ablation, for reasons that we do not yet understand, more die and don’t come back. In fact, over time, cells that survive the initial insult continue to die.”
“What we’ve observed is that we are able to achieve complete cell death using a combination of heating and then freezing at temperatures that alone would not be lethal to kill pancreatic cancer cells,” said Baumann.
Researchers heated and froze cancer cells and looked at the effect, using various technologies to determine the level of cell death, on regrowth as well as which cell stress pathways were activated.
“Using a variety of assays, we are able to determine the initial level of cell death as well as to what extent the surviving population is able to regrow,” Baumann said. “We were also able to determine the specific paths of cell death activated as a result of the dual thermal exposure.”
“When cells are disturbed—which means they are frozen or they see heat—various cell stress pathways are activated,” said Van Buskirk. “The interesting thing about cells, especially cancer cells, is that they will activate pathways to protect themselves. The objective of this line of molecular-based research is to find out which stress pathways are activated in pancreatic cancer cells so that we can better understand why dual-thermal ablation appears to be more effective.”
“Current studies are focused on elucidating which stress pathways specifically cause these cells to die or what is keeping them alive. That way, we can optimize this treatment to be as effective as possible against pancreatic cancer,” Baumann said.
According to Van Buskirk, modulating these stress pathways is the key to making the heating and freezing ablation process more effective. This could lead to the development of a new way to remove cancerous pancreatic tumors.
In addition to the cell molecular research, several members of the study team are working on developing new catheter technologies to deliver this ablative therapy to patients. “If a very thin catheter can be developed to target the tumor, and if we understand how pancreatic cancer responds to ablation at the molecular level, then we may be able to develop a new therapy to approach something that has been completely unapproachable, the targeted killing of a tumor in a very difficult place: the pancreas,” said Van Buskirk.
The Latest on: Pancreatic cancer
Breath test analysis spots pancreatic cancer
on July 18, 2018 at 10:53 am
Identifying certain compounds found in breath samples helped distinguish patients with pancreatic cancer from those without, according to research published in the British Journal of Surgery. George H... […]
Moleculin Expects to Meet FDA IND Filing Requirements for its Pancreatic Cancer Drug Candidate with Development Work in Australia
on July 18, 2018 at 6:52 am
HOUSTON, July 18, 2018 (GLOBE NEWSWIRE) -- Moleculin Biotech, Inc. (MBRX) ("Moleculin" or the "Company"), a clinical stage pharmaceutical company focused on the development of oncology drug candidates ... […]
Moleculin Biotech (MBRX) Expects to Meet FDA IND Filing Requirements for its Pancreatic Cancer Drug Candidate with Development Work in Australia
on July 18, 2018 at 4:32 am
Get instant alerts when news breaks on your stocks. Claim your 2-week free trial to StreetInsider Premium here. Moleculin Biotech, Inc. (Nasdaq: MBRX), a clinical stage pharmaceutical company focused ... […]
Breath tests may allow for earlier detection of pancreatic cancer
on July 17, 2018 at 11:57 pm
Axial CT image with i.v. contrast. Macrocystic adenocarcinoma of the pancreatic head. Credit: public domain Pancreatic cancer carries a very poor prognosis as most patients are diagnosed at an advance... […]
Breath analyses may help detect pancreatic cancer earlier, study shows
on July 17, 2018 at 11:41 pm
Pancreatic cancer carries a very poor prognosis as most patients are diagnosed at an advanced stage. Now a new BJS (British Journal of Surgery) study indicates that breath analyses may help detect pan... […]
High Fives presents Pancreatic Cancer Charity Fundraiser
on July 17, 2018 at 10:19 pm
High Fives is continuing the fight against the world’s toughest cancer by hosting its second annual Pancreatic Cancer Charity Fundraiser. The event will include a silent auction with gift certificates ... […]
Pancreas cancer benefit dedicated to former Wisconsin Badgers coach Jeff Sauer
on July 17, 2018 at 1:09 pm
An Aug. 12 benefit to support pancreas cancer research at UW Carbone Cancer Center is dedicated to the memory of former University of Wisconsin men's hockey coach Jeff Sauer. Roll & Stroll for Pancrea... […]
New technology helps researchers study pancreatic cancer
on July 16, 2018 at 2:03 pm
Pancreatic cancer kills 95 percent of the people diagnosed with it. Chemotherapy helps but is only able to extend survival for a few months. Now, researchers have a new tool allowing them to much more ... […]
Europe Pancreatic Cancer Epidemiology & Patient Flow Analysis 2018-2026 - ResearchAndMarkets.com
on July 13, 2018 at 6:25 am
DUBLIN--(BUSINESS WIRE)--Jul 13, 2018--The "Europe Pancreatic Cancer Epidemiology and Patient Flow Analysis - 2018" report has been added to ResearchAndMarkets.com's offering. The research provides in... […]
Pancreatic Cancer Survivor Shares His Appreciation for MSK Employees
on July 10, 2018 at 1:31 pm
This story originally appeared in Bridges, MSK’s newsletter for cancer survivors. Bridges offers a forum in which patients and their families can share stories of inspiration and hope, and of the chal... […]
via Google News and Bing News